PTSD Checklist for DSM-5 (PCL-5)

1. Abstract

The PTSD Checklist for DSM-5 (PCL-5) is an internationally recognized, 20-item self-report rating scale developed by the United States Department of Veterans Affairs National Center for PTSD. The instrument assesses the presence, frequency, and severity of Posttraumatic Stress Disorder (PTSD) symptoms as defined by the American Psychiatric Association’s Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). The instrument captures the four core diagnostic symptom clusters established in the DSM-5 criteria: Criterion B (Intrusion / Re-experiencing, 5 items), Criterion C (Avoidance, 2 items), Criterion D (Negative Alterations in Cognitions and Mood, 7 items), and Criterion E (Alterations in Arousal and Reactivity, 6 items). Respondents rate how much each symptom has bothered them over the past month using a 5-point Likert-type scale ranging from 0 (“Not at all”) to 4 (“Extremely”), generating a total symptom severity score between 0 and 80.

Extensive psychometric investigations across diverse clinical, veteran, active-duty military, and trauma-exposed civilian populations demonstrate outstanding internal consistency (Cronbach’s alpha typically exceeding α = .94 to .96) and robust test-retest reliability (r = .82 to .88). Confirmatory factor analyses (CFA) have validated both the formal DSM-5 four-factor model and advanced alternative structural models, notably the six-factor Anhedonia model and the seven-factor Hybrid model. Criterion validity has been established against gold-standard structured clinical interviews, including the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5), identifying an optimal diagnostic cut-point score typically ranging between 31 and 33. The PCL-5 functions as an indispensable measurement tool in clinical screening, diagnostic provisional assessment, symptom tracking, and intervention outcome monitoring in traumatic stress studies globally.

2. Keywords

PTSD Checklist for DSM-5, PCL-5, posttraumatic stress disorder, psychometrics, trauma assessment, DSM-5 criteria, symptom severity, screening instrument, CAPS-5, confirmatory factor analysis

3. Authors

The PCL-5 was developed in 2013 by senior behavioral science investigators and clinical psychologists associated with the National Center for PTSD, United States Department of Veterans Affairs:

• Frank W. Weathers, Ph.D. — Department of Psychology, Auburn University, Auburn, AL, USA.
• Brett T. Litz, Ph.D. — Massachusetts Veterans Epidemiological Research and Information Center (MAVERIC), VA Boston Healthcare System, and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
• Terence M. Keane, Ph.D. — Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System, and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
• Patrick A. Palmieri, Ph.D. — Center for the Treatment and Study of Traumatic Stress, Summa Health System, Akron, OH, USA.
• Brian P. Marx, Ph.D. — Behavioral Science Division, National Center for PTSD, VA Boston Healthcare System, and Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
• Paula P. Schnurr, Ph.D. — Executive Division, National Center for PTSD, White River Junction, VT, and Department of Psychiatry, Geisel School of Medicine at Dartmouth, Hanover, NH, USA.

Correspondence regarding institutional guidelines, administration protocols, and training modules may be directed to the National Center for PTSD via their official research distribution portal (VA National Center for PTSD).

4. Purpose

The primary purpose of the PTSD Checklist for DSM-5 is to provide a standardized, psychometrically rigorous self-report methodology for assessing the full spectrum of PTSD symptomatology in adults who have survived or witnessed traumatic events. Prior to the release of the DSM-5 in 2013, the diagnostic architecture of PTSD relied upon a three-factor triad established in DSM-IV (Re-experiencing, Avoidance/Numbing, and Hyperarousal), measured by the widely utilized PCL (with specific iterations including the PCL-C for civilian contexts, PCL-M for military cohorts, and PCL-S for specific traumatic events). The transition to DSM-5 eliminated these historical subtypes, consolidated trauma screening into a single core instrument, and expanded the diagnostic structure from 17 to 20 distinct symptoms grouped into four empirical clusters.

Clinically, the PCL-5 fulfills three foundational operational requirements:

• Screening and Provisional Diagnosis: It allows clinicians and primary care systems to identify individuals with probable PTSD rapidly. Using either a total dimensional threshold (recommended cut-point 31–33) or a symptom-cluster matching algorithm (requiring a minimum rating of 2 [“Moderately”] on diagnostic combinations across Criteria B through E), clinicians can determine the necessity of an in-depth clinical evaluation.
• Quantifying Symptom Severity: The measure generates continuous metric data across all four symptom clusters, offering a nuanced clinical profile of individual suffering. This enables practitioners to discern whether an individual is primarily burdened by intrusive cognitive-affective phenomena, phobic avoidance behaviors, profound emotional numbing, or severe physiological hyperreactivity.
• Treatment Outcome Monitoring: In evidence-based psychotherapies—such as Cognitive Processing Therapy (CPT), Prolonged Exposure (PE), and Eye Movement Desensitization and Reprocessing (EMDR)—the PCL-5 is administered iteratively (e.g., weekly or bi-weekly). Psychometric research shows that a decrease of 5 to 10 points reflects reliable clinical change, whereas an overall reduction of 10 to 13 points indicates a clinically meaningful response.

In epidemiological and translational research settings, the PCL-5 serves as a reliable surrogate index for diagnostic caseness, enabling large-scale longitudinal tracking, genetic association studies, neuroimaging symptom-correlation designs, and randomized controlled trial (RCT) efficacy endpoints without the excessive administrative burden of hours-long diagnostic interviews.

5. Psychological Construct

The psychological construct evaluated by the PCL-5 is posttraumatic stress pathology, defined as an intractable, maladaptive biobehavioral stress response syndrome triggered by exposure to actual or threatened death, serious injury, or sexual violence (Criterion A). The construct is operationalized into four distinct yet interrelated diagnostic domains comprising 20 explicit symptoms:

Criterion B: Intrusion / Re-experiencing (Items 1–5)

This dimension reflects the spontaneous, non-volitional recurrence of traumatic memory networks that bypass executive cognitive control. Rather than normal autobiographical remembering, intrusion symptoms involve affective and sensorimotor reenactments. The construct evaluates:

• Invasive, unprompted cognitive memories (Item 1).
• Recurrent distressing oneiric disturbances or nightmares reflecting trauma themes (Item 2).
• Dissociative states ranging from micro-flashbacks to complete loss of contextual reality awareness wherein the individual acts or feels as if the traumatic event is actively recurring in the present moment (Item 3).
• Acute subjective psychological distress upon encountering internal or external cues symbolizing the trauma (Item 4).
• Pronounced somatic and autonomic hyperreactivity (e.g., tachycardia, diaphoresis, dyspnea) triggered by trauma-related conditioned stimuli (Item 5).

Criterion C: Persistent Avoidance (Items 6–7)

Avoidance constitutes an overt behavioral and cognitive defense mechanism driven by negative reinforcement, wherein the trauma survivor actively circumvents trauma triggers to prevent emotional dysregulation:

• Cognitive/Internal Avoidance (Item 6): Voluntary, deliberate efforts to suppress, push away, or numb trauma-related thoughts, memories, images, or emotional reactions.
• Behavioral/External Avoidance (Item 7): Systematic avoidance of external environmental contingencies, including geographic locations, specific people, conversations, physical objects, or activities that evoke traumatic recall.

Criterion D: Negative Alterations in Cognitions and Mood (Items 8–14)

This expanded domain captures the profound disruption in cognitive schema, self-concept, worldview, and emotional capacity caused by traumatic events:

• Dissociative Amnesia (Item 8): Psychogenic inability to retrieve critical focal aspects of the traumatic memory, independent of head trauma or chemical intoxication.
• Pervasive Overgeneralized Schemas (Item 9): Catastrophic, rigid shifts in beliefs regarding oneself, others, or interpersonal safety (e.g., “I am irreparably damaged,” “The world is entirely hostile”).
• Distorted Causal Attributions (Item 10): Pathological self-blame or unrealistic externalized blame directed at others for the onset or aftermath of the trauma.
• Persistent Negative Affect (Item 11): Chronic state of neurovegetative dysphoria characterized by fear, horror, anger, guilt, or profound shame.
• Anhedonia and Social Disengagement (Items 12 & 13): Marked reduction in hedonic capacity, loss of behavioral engagement in previously valued activities, and subjective feelings of emotional alienation or detachment from family and peers.
• Constricted Affect (Item 14): Profound emotional numbing marked by an inability to experience warm, loving, joyous, or intimate human emotions.

Criterion E: Alterations in Arousal and Reactivity (Items 15–20)

This subscale evaluates tonic dysregulation of the autonomic nervous system, characterized by sympathetic hyperarousal and diminished prefrontal inhibitory modulation:

• Irritability and Aggression (Item 15): Diminished threshold for frustration, verbal outbursts, or aggressive behavioral escalation with minimal provocation.
• Reckless or Self-Destructive Behavior (Item 16): Impulsive disregard for physical safety, such as reckless driving, substance bingeing, or dangerous thrill-seeking.
• Hypervigilance (Item 17): Continuous, scanning attentional bias toward prospective environmental threats; an enduring state of physiological readiness for attack.
• Exaggerated Startle Response (Item 18): Abnormal somatic and autonomic reactivity to sudden sensory stimuli (e.g., loud noises, sudden visual movements).
• Cognitive Dispersion (Item 19): Inability to marshal executive working memory or sustain focal attention during cognitive tasks.
• Sleep Architecture Disruption (Item 20): Severe insomnia, sleep fragmentation, or hyper-aroused nocturnal awakenings.

6. Theoretical Framework

The theoretical architecture undergirding the PCL-5 draws from contemporary cognitive-behavioral, neurobiological, and information-processing paradigms of trauma spectrum disorders:

Emotional Processing Theory (Foa & Kozak)

According to Emotional Processing Theory, formulated by Edna Foa and Michael Kozak, pathological fear manifests as an interconnected cognitive network stored in long-term associative memory. This memory network incorporates three types of information: information about the feared stimulus, information regarding behavioral and physiological responses, and interpretive meaning structures linking stimulus cues to existential threat. In PTSD, this fear network is maladaptively broad, characterized by erroneous associations and overgeneralized meaning (e.g., interpreting non-threatening contexts as life-threatening). Criterion B items reflect the automated activation of this network, while Criterion C items reflect safety-seeking avoidance behaviors that prevent corrective cognitive updating.

Cognitive Model of Chronic PTSD (Ehlers & Clark)

Anke Ehlers and David M. Clark propose that persistent PTSD occurs when individuals process the trauma memory in a manner that creates a sense of imminent, continuous threat. This stems from two interrelated processes:

• Negative Appraisals: Individuals formulate extreme negative appraisals regarding the trauma and its aftermath (captured by Criterion D, Items 9–11). The survivor interprets their own symptoms (e.g., emotional numbness, intrusive flashbacks) as signs of impending insanity or unworthiness.
• Memory Fragmentation: Due to disrupted encoding during extreme sympathetic arousal, the traumatic memory is retrieved automatically by sensory perceptual cues without conscious temporal contextualization (Criterion B). Avoidance behaviors and thought suppression prevent elaboration and integration of the memory into the autobiographical knowledge base.

Dual Representation Theory (Brewin)

Chris Brewin’s Dual Representation Theory posits two distinct memory systems: Verbally Accessible Memory (VAM) and Situationally Accessible Memory (SAM). Under non-traumatic conditions, hippocampal processing integrates conscious memories into contextual biographical frameworks. During traumatic terror, high levels of neurochemical stress hormones (norepinephrine, glucocorticoids) impair hippocampal synaptic plasticity while hyper-potentiating the basolateral amygdala. Consequently, trauma memories are stored in an unintegrated, sensory-bound format (SAMs). The PCL-5 items track the persistent, spontaneous replay of SAMs (intrusions, physiological arousal) and the respondent’s maladaptive secondary psychological defenses against them.

7. Validity

The PCL-5 has undergone psychometric validation across diverse clinical, civilian, and veteran cohorts worldwide. Validity studies consistently indicate that the instrument mirrors the diagnostic criteria of the DSM-5 with high fidelity.

Convergent and Discriminant Validity

Extensive studies, notably by Blevins et al. (2015) and Bovin et al. (2016), have demonstrated that the PCL-5 exhibits strong convergent validity with other measures of trauma-related distress. In validation samples, PCL-5 total scores correlate strongly with:

• The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): r values typically range from .77 to .85.
• The PTSD Checklist for DSM-IV (PCL-C / PCL-M): r = .84 to .90.
• Measures of comorbid psychopathology, including the Patient Health Questionnaire-9 (PHQ-9; r = .70–.74) and the Generalized Anxiety Disorder-7 (GAD-7; r = .68–.76).

Discriminant validity is supported by lower correlations with theoretically distinct constructs, such as physical health impairment scales (e.g., SF-36 physical functioning subscales, r = .20–.32) and generalized substance misuse indices when controlling for underlying affective distress.

Criterion-Related and Diagnostic Utility

Receiver Operating Characteristic (ROC) curve analyses against CAPS-5 diagnostic classifications identify an area under the curve (AUC) consistently between .89 and .93, reflecting excellent diagnostic discrimination. Key diagnostic threshold findings include:

• Bovin et al. (2016) Veteran Cohort: A total score cut-off between 31 and 33 demonstrated optimal balance between diagnostic sensitivity (.88) and specificity (.69), with an overall diagnostic accuracy exceeding 80%.
• Wortmann et al. (2016) Civilian Trauma Cohort: A cut-point of 31–33 yielded optimal diagnostic performance, confirming invariance of the threshold across military and non-military populations.
• Symptom Cluster Algorithm: When evaluated using the DSM-5 diagnostic rule (treating items rated ≥ 2 as positive symptoms), the algorithm exhibits high specificity (.80–.86) but slightly lower sensitivity (.65–.74) relative to the continuous threshold score.

8. Reliability

The PCL-5 exhibits strong reliability across a wide range of administrative formats, time intervals, and diverse demographic groups:

Internal Consistency

Internal consistency metrics for the full 20-item instrument regularly exceed psychometric standards. In foundational validation cohorts (Blevins et al., 2015; Bovin et al., 2016; Ashbaugh et al., 2016):

• Total instrument Cronbach’s alpha (α) ranges between .94 and .97.
• Criterion B (Intrusions) subscale α ranges from .85 to .90.
• Criterion C (Avoidance) subscale α ranges from .79 to .86.
• Criterion D (Negative Alterations in Cognitions/Mood) subscale α ranges from .86 to .91.
• Criterion E (Arousal/Reactivity) subscale α ranges from .83 to .89.
• McDonald’s omega (ω) values similarly exceed .95 for the composite scale, demonstrating that item variance is attributable to the underlying trauma distress latent factor.

Test-Retest Reliability

Temporal stability is well documented across clinical and research timelines:

• Short-term test-retest reliability over intervals of 1 to 7 days in stable clinical cohorts yields Pearson correlation coefficients ranging from r = .82 to .88 (Blevins et al., 2015).
• Intraclass Correlation Coefficients (ICC) for total scores across brief intervals typically exceed .85, indicating high temporal stability in the absence of therapeutic intervention.

9. Factor Analysis

The structural topology of the PCL-5 has been evaluated through extensive exploratory (EFA) and confirmatory factor analyses (CFA). While the tool was constructed to assess the four DSM-5 clusters, contemporary structural equation modeling demonstrates that alternative dimensional models often show superior fit:

Evaluated Structural Models

• DSM-5 Four-Factor Model: Intrusion (items 1–5), Avoidance (items 6–7), Negative Alterations in Cognition and Mood (items 8–14), and Hyperarousal (items 15–20). While demonstrating adequate fit (Root Mean Square Error of Approximation [RMSEA] ≈ .055–.065; Comparative Fit Index [CFI] ≈ .91–.93), it is frequently outperformed by more differentiated models.
• Six-Factor Anhedonia Model: Proposed by Liu et al. (2014), separating Criterion D and E symptoms into Intrusion, Avoidance, Negative Affect, Anhedonia, Dysphoric Arousal, and Anxious Arousal.
• Seven-Factor Hybrid Model: Introduced by Armour et al. (2015), this model refines the structure into seven distinct latent factors:
  1. Intrusion (Items 1–5)
  2. Avoidance (Items 6–7)
  3. Negative Affect (Items 9–11)
  4. Anhedonia (Items 12–14)
  5. Externalizing Behaviors (Items 15–16)
  6. Anxious Arousal (Items 17–18)
  7. Dysphoric Arousal (Items 8, 19, 20)

Across multiple structural studies (e.g., Bovin et al., 2016; Wortmann et al., 2016; Ashbaugh et al., 2016), the Armour seven-factor hybrid model consistently yields superior statistical fit indices (RMSEA ≈ .038–.045, CFI > .96, TLI > .95, BIC minimized), providing empirical support for the separation of generalized dysphoria from distinct posttraumatic fear processing and externalizing symptoms.

10. Instrument / Measurement Tool

• Instrument Name: PTSD Checklist for DSM-5 (PCL-5)
• Authoring Body: National Center for PTSD, U.S. Department of Veterans Affairs
• Assessment Type: Standardized Self-Report Rating Scale
• Item Count: 20 items (corresponding directly to the 20 DSM-5 PTSD symptoms)
• Target Population: Adults (≥ 18 years) exposed to traumatic stress; adolescent adaptations exist under specialized protocols
• Administration Modality: Paper-and-pencil, computer-based assessment, or clinical interview prompt
• Completion Time: 5 to 10 minutes
• Reference Recall Window: “In the past month” (or “in the past week” when tracking rapid clinical change during active treatment)
• Authentic Response Scale: 5-point Likert scale:
  • 0 = Not at all
  • 1 = A little bit
  • 2 = Moderately
  • 3 = Quite a bit
  • 4 = Extremely
• Scoring and Diagnostic Interpretation:
  • Total Severity Score: Calculated by summing all 20 individual items. Theoretical range: 0 to 80. Higher scores indicate greater PTSD symptom severity.
  • DSM-5 Symptom Cluster Subscale Scores:
    • Criterion B (Intrusion / Re-experiencing): Sum of items 1–5 (range: 0–20).
    • Criterion C (Avoidance): Sum of items 6–7 (range: 0–8).
    • Criterion D (Negative alterations in cognitions and mood): Sum of items 8–14 (range: 0–28).
    • Criterion E (Alterations in arousal and reactivity): Sum of items 15–20 (range: 0–24).
  • Provisional Diagnostic Rules:
    • Rule 1 (Cut-Point Criterion): A total score of 31 to 33 indicates probable PTSD requiring formal clinical evaluation.
    • Rule 2 (DSM-5 Diagnostic Algorithm): Endorsement of an item is defined as a rating of ≥ 2 (“Moderately”). A provisional diagnosis requires endorsing at least:
      • ≥ 1 Criterion B item (Items 1–5)
      • ≥ 1 Criterion C item (Items 6–7)
      • ≥ 2 Criterion D items (Items 8–14)
      • ≥ 2 Criterion E items (Items 15–20)
  • Meaningful Change Metrics: A change of 5 to 10 points indicates reliable individual change; a reduction of 10 to 13 points denotes clinically significant symptom reduction.

11. Permissions & Fee and Test Year

The PCL-5 was developed in 2013 by staff psychologists at the United States Department of Veterans Affairs National Center for PTSD. As an instrument created by federal employees in the course of their official duties, the PCL-5 is in the public domain and is available free of charge for non-commercial clinical, educational, and scientific research use.

No formal licensing fees or commercial royalties are required to administer the measure. However, investigators and practitioners must adhere to ethical standards of psychological assessment and the usage terms established by the VA National Center for PTSD. The instrument’s wording, response categories, and instruction stems should not be altered, truncated, or adapted without prior formal consultation, as modifications may compromise the psychometric validity of established diagnostic thresholds. Commercial entities distributing software, automated electronic medical records (EMR) systems, or fee-based clinical platforms containing the PCL-5 should review distribution permissions via the VA National Center for PTSD website.

12. References

• Armour, C., Tsai, J., Durham, T. A., Charak, R., Biehn, T. L., Elhai, J. D., & Pietrzak, R. H. (2015). DSM-5 posttraumatic stress disorder: Factor structure, levels of dysphoria, and anhedonia in a nationally representative sample of US veterans. Social Psychiatry and Psychiatric Epidemiology, 50(6), 879–890. https://doi.org/10.1007/s00127-015-1033-6
• Ashbaugh, A. R., Houle-Johnson, S., Herbert, C., El-Hage, W., & Brunet, A. (2016). Psychometric properties of the English and French versions of the Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5) in a college sample. Canadian Journal of Behavioural Science / Revue canadienne des sciences du comportement, 48(4), 289–299. https://doi.org/10.1037/cbs0000050
• Blevins, C. A., Weathers, F. W., Davis, M. T., Witte, T. K., & Domino, J. L. (2015). The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28(6), 489–498. https://doi.org/10.1002/jts.22059
• Bovin, M. J., Marx, B. P., Weathers, F. W., Gallagher, M. W., Rodriguez, P., Schnurr, P. P., & Keane, T. M. (2016). Psychometric properties of the PTSD Checklist for Diagnostic and Statistical Manual of Mental Disorders–Fifth Edition (PCL-5) in veterans. Psychological Assessment, 28(11), 1379–1391. https://doi.org/10.1037/pas0000254
• Brewin, C. R. (2014). Episodic memory, perceptual memory, and their interaction: Foundations for a theory of posttraumatic stress disorder. Psychological Bulletin, 140(1), 69–97. https://doi.org/10.1037/a0033722
• Ehlers, A., & Clark, D. M. (2000). A cognitive model of posttraumatic stress disorder. Behaviour Research and Therapy, 38(4), 319–345. https://doi.org/10.1016/S0005-7967(99)00123-0
• Foa, E. B., & Kozak, M. J. (1986). Emotional processing of fear: Exposure to corrective information. Psychological Bulletin, 99(1), 20–35. https://doi.org/10.1037/0033-2909.99.1.20
• Liu, P., Wang, L., Cao, C., Wang, R., Zhang, J., Zhang, B., Wu, Q., & Elhai, J. D. (2014). The underlying dimensions of DSM-5 posttraumatic stress disorder symptoms in an epidemiological sample of Chinese earthquake victims. Journal of Anxiety Disorders, 28(4), 345–351. https://doi.org/10.1016/j.janxdis.2014.03.008
• Weathers, F. W., Litz, B. T., Keane, T. M., Palmieri, P. A., Marx, B. P., & Schnurr, P. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). National Center for PTSD. Available from https://www.ptsd.va.gov/
• Wortmann, J. H., Jordan, A. H., Weathers, F. W., Resick, P. A., Dondanville, K. A., Hall-Clark, B., Foa, E. B., Young-McCaughan, S., Mintz, J., Litz, B. T., & Peterson, A. L. (2016). Psychometric analysis of the PTSD Checklist–5 (PCL-5) among treatment-seeking military service members. Journal of Traumatic Stress, 29(4), 346–354. https://doi.org/10.1002/jts.22116

13. Items of the Scale (Questionnaire)